Discontinued — last reported Q3 '25
GE HealthCare Technologies Deferred Tax Assets increased by 32.6% to $256.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 61.0%, from $159.00M to $256.00M. Over 3 years (FY 2022 to FY 2025), Deferred Tax Assets shows a downward trend with a -19.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase can signal future tax efficiency or the utilization of past losses, while a decrease may indicate the realization of those benefits.
These are assets on the balance sheet that represent future tax savings resulting from temporary differences between the...
Common in large, capital-intensive companies; peers with significant R&D spending often have large deferred tax assets from tax credits.
deferred_tax_assets| Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $370.00M | $64.00M | $81.00M | $62.00M | $68.00M | $68.00M | $55.00M | $59.00M | $56.00M | $159.00M | $173.00M | $171.00M | $193.00M | $256.00M |
| QoQ Change | — | -82.7% | +26.6% | -23.5% | +9.7% | +0.0% | -19.1% | +7.3% | -5.1% | +183.9% | +8.8% | -1.2% | +12.9% | +32.6% |
| YoY Change | — | — | — | — | -81.6% | +6.3% | -32.1% | -4.8% | -17.6% | +133.8% | +214.5% | +189.8% | +244.6% | +61.0% |